1-9 of 9
Merit Hanna
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Is initial treatment with dasatinib for newly diagnosed chronic Phase chronic myeloid leukemia, followed by switching to imatinib for those that achieve MR3.0 at 12 months, an effective strategy? Results of the Phase 2 kinase inhibition with sprycel startup study

Free
Peter Browett, Zhenqiang Wu, Humphrey Pullon, Jenny Yoon, Melissa Firth, Shani Peleg, Emma-Jane McDonald, Sarah Benge, Bart Baker, Merit Hanna, Victoria Campion, Shahidul Islam, Gordon Royle, Nicky Lawrence, Katrina Sharples, Lucy Pemberton
Journal: Blood
Blood (2025) 146 (Supplement 1): 2006.
https://doi.org/10.1182/blood-2025-2006
Published: 2025
Journal Articles

Shorespan-017: Phase 3 extension study for safety of bomedemstat in participants with essential thrombocythemia who received bomedemstat from a prior clinical study

Free
David Ross, Andrew Wilson, Tara Cochrane, William Stevenson, James Liang, Marco Brociner, Francesca Palandri, Stephen Larsen, Merit Hanna, Alessandro Maria Vannucchi, Kristen Pettit, Natalia Curto-Garcia, Harinder Gill, Uche Okoro, Jonas Jutzi, Patricia Marinello, Monia Marchetti
Journal: Blood
Blood (2025) 146 (Supplement 1): 2033.
https://doi.org/10.1182/blood-2025-2033
Published: 2025
Journal Articles

Impact of belantamab mafodotin–containing regimens on renal function in patients with Relapsed/Refractory multiple myeloma (RRMM) and mild/moderate renal impairment in the dreamm-7 and dreamm-8 trials

Free
Marcelo Pitombeira de Lacerda, Meletios Dimopoulos, Ludek Pour, Kihyun Kim, Sergei Voloshin, Hanlon Sia, Esther González García, Chang-Ki Min, Anna Sureda Balarí, Ivan Špička, Pawel Robak, Marek Hus, Vera Zherebtsova, Merit Hanna, Vinay Jadhav, Jorge Mouro, Zeyad Khalaf, Nick Pirooz, Ianire Garrobo-Calleja, Lydia Eccersley, Elisabet Manasanch, Vania Hungria, Meral Beksac
Journal: Blood
Blood (2025) 146 (Supplement 1): 2260.
https://doi.org/10.1182/blood-2025-2260
Published: 2025
Journal Articles

Bomedemstat (IMG-7289), an LSD1 Inhibitor, Manages the Signs and Symptoms of Essential Thrombocythemia (ET) While Reducing the Burden of Cells Homozygous for Driver Mutations

Free
Joachim R. Goethert, Harinder Gill, Francesca Palandri, David M. Ross, Tara Cochrane, Stephen R. Larsen, Anna B. Halpern, Jake Shortt, James M. Rossetti, James Liang, Monia Marchetti, Andrew J. Wilson, Andrew Innes, Merit Hanna, William S. Stevenson, Alessandro M. Vannucchi, Maria Kleppe, Georges Natsoulis, Claire N Harrison, Hugh Young Rienhoff Jr.
Journal: Blood
Blood (2023) 142 (Supplement 1): 747.
https://doi.org/10.1182/blood-2023-179329
Published: 2023
Journal Articles

A Phase 2 Study of the LSD1 Inhibitor Bomedemstat (IMG-7289) for the Treatment of Essential Thrombocythemia (ET)

Free
Harinder Gill, Francesca Palandri, David M Ross, Tara Cochrane, Courtney Tate, Steven W Lane, Stephen R Larsen, Aaron T. Gerds, Anna B. Halpern, Jake Shortt, James M. Rossetti, Kristen M. Pettit, James Liang, Adam J Mead, Monia Marchetti, Alessandro M. Vannucchi, Andrew J Wilson, Joachim R Göthert, Merit Hanna, Francesco Passamonti, William S Stevenson, Claire Harrison, Moshe Talpaz, Nicola Vianelli, Hugh Young Rienhoff, Jr.
Journal: Blood
Blood (2022) 140 (Supplement 1): 1784–1787.
https://doi.org/10.1182/blood-2022-159047
Published: 2022
Journal Articles

Conservative Management of Hemochromatosis without Long-Term Maintenance Venesections in Patients with Moderate Iron Burden

Free
Jenny Sumin Yoon, MBChB, Ross Alistair Henderson, MBChB FRACP FRCPA PhD, Merit Hanna, MBChB FRCPA, Eileen Merriman, MBChB BMLSc FRACP FRCPA PhD, Anna Elinder, MBChB FRACP FRCPA, Gilly Selman, MLS, Leone Kennedy, BN PGCertHSc, Henry Chan, MBChB, FRACP, FRCPA
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–45.
https://doi.org/10.1182/blood-2020-136534
Published: 2020
Journal Articles

Single Centre Experience in Treating Elderly Patients with Acute Myeloid Leukaemia or High Risk Myelodysplastic Syndrome with a Combination of Low Dose Cytarabine, Venetoclax and Fluconazole (VeLDAC-F)

Free
Lauren Child, Henry Chan, MBChB, Ross Alistair Henderson, PhD MBChB, Anna Elinder, MBChB, Eileen Merriman, MBChB, Merit Hanna, MBChB, David Simpson, MBChB, FRACP, FRCPA
Journal: Blood
Blood (2018) 132 (Supplement 1): 5220.
https://doi.org/10.1182/blood-2018-99-115993
Published: 2018
Journal Articles

Once Weekly Subcutanous Bortezomib with Cyclophosphamide and Dexamethasone Is Well Tolerated and Effective As Initial Treatment in Symptomatic Multiple Myeloma

Free
David Simpson, FRACP, FRCPA, MBChB, James Liang, MBChB, Ross Henderson, MBChB, PhD, FRACP, FRCPA, Merit Hanna, MBChB, FRCPA, Eileen Merriman, MBChB, FRACP, FRCPA
Journal: Blood
Blood (2012) 120 (21): 4049.
https://doi.org/10.1182/blood.V120.21.4049.4049
Published: 2012
Journal Articles

Thalidomide: An Active Agent in AILT Lymphoma

Free
Ross Henderson, David Simpson, MBChB, FRACP, FRCPA, Merit Hanna, MBChB, FRCPA, Sanjeev Chunilal
Journal: Blood
Blood (2008) 112 (11): 4960.
https://doi.org/10.1182/blood.V112.11.4960.4960
Published: 2008